Fatty Liver Disease (FLD) Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Clinical Characteristics of Metabolic Associated Fatty Liver Disease
Conditions: Metabolic Associated Fatty Liver Disease; Clinical Features Sponsors: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials

Development of a Novel Asian Mediterranean Diet and Its Acceptability in NAFLD
Conditions: Fatty Liver, Nonalcoholic Sponsors: Singapore Institute of Technology; Singapore Health Services Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials

Lifestyle intervention in children with obesity and nonalcoholic fatty liver disease (NAFLD): study protocol for a randomized controlled trial in Ningbo city (the SCIENT study)
This study aimed to develop an m-Health-assisted lifestyle intervention program targeting overweight/obese children and assess its effectiveness on indicators of adiposity and NAFLD.MethodsThis is a cluster-randomized controlled trial that conducted in children with overweight/obesity in Ningbo city, Zhejiang Province, China. Students in Grade 3 (8 –10 years old) were recruited from six primary schools, with three be randomized to intervention group and three to usual practice group. The intervention program will last for one academic year and consists of health education, dietary guidance, and physical activity reinfor...
Source: Trials - March 20, 2024 Category: Research Source Type: clinical trials

Clinical Study Evaluating the Safety and Efficacy of Esomeprazole in Treatment of Non-alcoholic Steatohepatitis
Conditions: Fatty Liver Disease; Steatohepatitis, Nonalcoholic Interventions: Drug: Esomeprazole; Drug: Placebo Sponsors: Sadat City University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials

Combining Gene Variants to Improve Risk Prediction for Metabolic (Dysfunction)- Associated Fatty Liver Disease and Its Progression to Cirrhosis in Indian Individuals With Type 2 Diabetes
Conditions: Type2diabetes Sponsors: Medanta, The Medicity, India Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials

Efficacy Evaluation of Chang Geng Healthy Drink on Patients With Non-alcoholic Fatty Liver Disease
Conditions: Non-Alcoholic Fatty Liver Disease Interventions: Other: Chang Geng Healthy Drink Sponsors: Chang Gung Memorial Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2024 Category: Research Source Type: clinical trials

Different Exercise Modalities in the Treatment of NAFLD and Their Impact on Myokines
Conditions: NAFLD; Nonalcoholic Fatty Liver Disease; Fatty Liver, Nonalcoholic; Fatty Liver Interventions: Other: Exercise; Behavioral: Motivational Interviewing Sponsors: Yeditepe University; TUB İTAK Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2024 Category: Research Source Type: clinical trials

A Clinical Study of Curcuvail ® in Patients With Non-alcoholic Fatty Liver Disease
Conditions: Fatty Liver Without Mention of Alcohol Interventions: Drug: Test Product: Curcuvail ® 250mg capsule (Curcuma longa Extractcontaining 35% Curcuminoids); Drug: Placebo product Sponsors: COD Research Private Ltd Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials

Efficacy of Canagliflozin Versus Metformin in Women With Polycystic Ovary Syndrome
Conditions: Polycystic Ovary Syndrome; Non-Alcoholic Fatty Liver Disease Interventions: Drug: Canagliflozin 100mg Tab; Drug: Metformin Hydrochloride Sponsors: Ping Li,MD Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials

Effect of a Food Supplementation With a Combined Food Supplement on Lipid Pattern, Indexes of Non-alcoholic Fatty Liver Disease and Systemic Inflammation
Conditions: Hypercholesterolemia Interventions: Dietary Supplement: Dietary Supplement; Other: Placebo Sponsors: University of Bologna Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2024 Category: Research Source Type: clinical trials

Clinical Trials Using HepatoKeeper Herbal Essentials to Treat Non-alcoholic Fatty Liver Disease and Metabolic Factors
Conditions: Non-alcoholic Fatty Liver Disease; Liver Fibrosis; Liver Injury Interventions: Drug: Ganwei; Drug: Metformin; Drug: Placebo Sponsors: Taipei City Hospital; The One Biopharmaceutical Co., Ltd. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2024 Category: Research Source Type: clinical trials

Direct Versus Indirect Effect of Amino Acids on Hepatokines
Conditions: Non-Alcoholic Fatty Liver Disease; Obesity Interventions: Other: Evaluating the acute effect of an amino acid infusion with and without a concomitant infusion of the somatostatin analogue octreotide to eliminate endogenous production of glucagon Sponsors: University of Copenhagen; Bispebjerg Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials

Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Non-Alcoholic Fatty Liver Disease (PARADISE-NAFLD)
Conditions: Non-alcoholic Fatty Liver Disease Interventions: Device: focused power ultrasound mediated inferior perirenal adipose tissue modification; Device: sham-control group Sponsors: The First Affiliated Hospital with Nanjing Medical University; The Affiliated Jiangning Hospital of Nanjing Medical University; Suzhou Municipal Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2024 Category: Research Source Type: clinical trials

Exploratory Analysis of Enhanced Liver Function (ELF) Test to Detect Early Fatty Liver in High Risk Population
Conditions: Fatty Liver Sponsors: Methodist Health System Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials

A Nutrigenetic Intervention in MASLD
Conditions: NAFLD; Fatty Liver Interventions: Behavioral: Dietary intervention Sponsors: Maastricht University; Istanbul University - Cerrahpasa (IUC) Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 24, 2024 Category: Research Source Type: clinical trials